Puma Biotechnology (PBYI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PBYI | ABOS | SGMT | ||
| Company | Puma Biotechnology | Acumen Pharmaceuticals Inc | Sagimet Biosciences Inc Series A | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.88 | 2.40 | 4.46 | ||
| High | 2.98 | 2.40 | 4.76 | ||
| Low | 2.79 | 2.25 | 4.27 | ||
| Last | 2.90 | 2.31 | 4.50 | ||
| Change | +0.06 | -0.06 | -0.02 | ||
| % Change | +2.11% | -2.53% | -0.44% | ||
| Volume | 404,700 | 129,000 | 502,100 | ||
| 20-Day Average Volume | 576,860 | 215,215 | 711,040 | ||
| Previous Close | 2.84 | 2.37 | 4.52 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 2.91 | 2.79 | 5.41 | ||
| 20-Day Raw Stochastic | 48.74% | 7.08% | 14.03% | ||
| 20-Day Relative Strength | 51.25% | 41.85% | 45.24% | ||
| Weighted Alpha | -31.72 | -22.19 | -58.28 | ||
| Today's Opinion | 64% Sell | 72% Sell | 40% Buy | ||
| Previous Opinion | 64% Sell | 72% Sell | 40% Buy | ||
| Last Month's Opinion | 40% Sell | 40% Sell | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.01% since 11/14/24 | -11.49% since 11/14/24 | -13.13% since 11/14/24 | ||
| Low | 2.32 on 11/18/24 | 2.23 on 11/19/24 | 4.19 on 11/19/24 | ||
| High | 3.01 on 11/15/24 | 2.62 on 11/15/24 | 5.18 on 11/15/24 | ||
| 1-Month | |||||
| %Chg | +3.20% since 10/21/24 | -14.44% since 10/21/24 | -19.21% since 10/21/24 | ||
| Low | 2.32 on 11/18/24 | 2.23 on 11/19/24 | 4.19 on 11/19/24 | ||
| High | 3.51 on 11/08/24 | 3.36 on 11/11/24 | 6.40 on 11/13/24 | ||
| 3-Month | |||||
| %Chg | +7.41% since 08/21/24 | -18.95% since 08/21/24 | +46.10% since 08/21/24 | ||
| Low | 2.22 on 09/06/24 | 2.15 on 09/06/24 | 2.52 on 09/06/24 | ||
| High | 3.51 on 11/08/24 | 3.36 on 11/11/24 | 6.40 on 11/13/24 | ||
| 6-Month | |||||
| %Chg | -30.46% since 05/21/24 | -39.37% since 05/21/24 | -6.05% since 05/21/24 | ||
| Low | 2.22 on 09/06/24 | 2.08 on 06/26/24 | 2.39 on 08/14/24 | ||
| High | 4.44 on 05/22/24 | 3.90 on 05/22/24 | 6.40 on 11/13/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 139,410 | 142,390 | 138,651 | ||
| Shares Outstanding, K | 49,088 | 60,080 | 30,675 | ||
| Annual Sales | 235,640,000 | 0 | 2,000,000 | ||
| Annual Net Income | 21,590,000 | -52,370,000 | -27,880,000 | ||
| Last Quarter Sales | 80,540,000 | 0 | 0 | ||
| Last Quarter Net Income | 20,320,000 | -29,770,000 | -14,620,000 | ||
| 60-Month Beta | 1.09 | 0.04 | 2.29 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.45 on 11/07/24 | -0.50 on 11/12/24 | -0.45 on 11/14/24 | ||
| Latest Earnings Date | 11/07/24 | 11/12/24 | 11/18/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 5.71 | 0.00 | 0.00 | ||